Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection

Summary: Background: The majority of those infected by ancestral Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) during the UK first wave (starting March 2020) did not require hospitalisation. Most had a short-lived mild or asymptomatic infection, while others had symptoms that persist...

Full description

Bibliographic Details
Main Authors: Gabriella Captur, James C. Moon, Constantin-Cristian Topriceanu, George Joy, Leo Swadling, Jenny Hallqvist, Ivan Doykov, Nina Patel, Justyna Spiewak, Tomas Baldwin, Matt Hamblin, Katia Menacho, Marianna Fontana, Thomas A. Treibel, Charlotte Manisty, Ben O'Brien, Joseph M. Gibbons, Corrina Pade, Tim Brooks, Daniel M. Altmann, Rosemary J. Boyton, Áine McKnight, Mala K. Maini, Mahdad Noursadeghi, Kevin Mills, Wendy E. Heywood
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:EBioMedicine
Subjects:
COVID-19
Proteomics
Post-acute sequelae of SARS-CoV-2 (PASC)
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396422004753

Internet

http://www.sciencedirect.com/science/article/pii/S2352396422004753

Similar Items